These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 15272313

  • 1. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
    Liao Y, Zou YY, Xia WY, Hung MC.
    Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
    [Abstract] [Full Text] [Related]

  • 2. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.
    Ueno NT, Bartholomeusz C, Herrmann JL, Estrov Z, Shao R, Andreeff M, Price J, Paul RW, Anklesaria P, Yu D, Hung MC.
    Clin Cancer Res; 2000 Jan; 6(1):250-9. PubMed ID: 10656456
    [Abstract] [Full Text] [Related]

  • 3. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene.
    Ueno NT, Bartholomeusz C, Xia W, Anklesaria P, Bruckheimer EM, Mebel E, Paul R, Li S, Yo GH, Huang L, Hung MC.
    Cancer Res; 2002 Nov 15; 62(22):6712-6. PubMed ID: 12438271
    [Abstract] [Full Text] [Related]

  • 4. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
    Ueno NT, Yu D, Hung MC.
    Oncogene; 1997 Aug 18; 15(8):953-60. PubMed ID: 9285690
    [Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr 18; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 6. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC.
    Oncogene; 1997 Feb 06; 14(5):561-8. PubMed ID: 9053854
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H, Zhang L, Tang Y, Deisseroth A.
    Cancer Gene Ther; 2003 May 06; 10(5):388-95. PubMed ID: 12719708
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism.
    Brader KR, Wolf JK, Hung MC, Yu D, Crispens MA, van Golen KL, Price JE.
    Clin Cancer Res; 1997 Nov 06; 3(11):2017-24. PubMed ID: 9815592
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
    Clarke K, Lee FT, Brechbiel MW, Smyth FE, Old LJ, Scott AM.
    Clin Cancer Res; 2000 Sep 06; 6(9):3621-8. PubMed ID: 10999754
    [Abstract] [Full Text] [Related]

  • 10. Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice.
    Li J, Dong X, Xu Z, Jiang X, Jiang H, Krissansen GW, Sun X.
    J Biomed Sci; 2008 Jan 06; 15(1):99-109. PubMed ID: 17705027
    [Abstract] [Full Text] [Related]

  • 11. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.
    Melquist JJ, Kacka M, Li Y, Malaeb BS, Elmore J, Baseman AG, Hsieh JT, Koeneman KS.
    Urol Oncol; 2006 Jan 06; 24(4):362-71. PubMed ID: 16818192
    [Abstract] [Full Text] [Related]

  • 12. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.
    Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC.
    Oncogene; 1995 Oct 05; 11(7):1383-8. PubMed ID: 7478560
    [Abstract] [Full Text] [Related]

  • 13. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov 05; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]

  • 14. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y, Shen K, He CX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep 05; 42(9):617-22. PubMed ID: 17983518
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16.
    Zhou RR, Jia SF, Zhou Z, Wang Y, Bucana CD, Kleinerman ES.
    Cancer Gene Ther; 2002 May 05; 9(5):407-13. PubMed ID: 11961663
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X, Jung C, Liu YH, Bae KH, Zhang YP, Zhang HJ, Vanderputten D, Jeng MH, Gardner TA, Kao C.
    J Gene Med; 2006 Jun 05; 8(6):679-89. PubMed ID: 16570242
    [Abstract] [Full Text] [Related]

  • 17. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct 05; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 18. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation.
    Shao R, Lee DF, Wen Y, Ding Y, Xia W, Ping B, Yagita H, Spohn B, Hung MC.
    Mol Cancer Res; 2005 Apr 05; 3(4):219-26. PubMed ID: 15831675
    [Abstract] [Full Text] [Related]

  • 19. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
    Cook JL, Miura TA, Iklé DN, Lewis AM, Routes JM.
    Cancer Res; 2003 Jun 15; 63(12):3435-43. PubMed ID: 12810682
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo.
    Deng J, Xia W, Hung MC.
    Oncogene; 1998 Oct 29; 17(17):2167-75. PubMed ID: 9811448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.